loadpatents
Patent applications and USPTO patent grants for SEIBEL; William.The latest application filed is for "rational therapeutic targeting of oncogenic immune signaling states in myeloid malignancies via the ubiquitin conjugating enzyme ube2n".
Patent | Date |
---|---|
Rational Therapeutic Targeting Of Oncogenic Immune Signaling States In Myeloid Malignancies Via The Ubiquitin Conjugating Enzyme Ube2n App 20220267753 - STARCZYNOWSKI; Daniel ;   et al. | 2022-08-25 |
Sos1 Allosteric Site Targeting App 20210338694 - Zheng; Yi ;   et al. | 2021-11-04 |
Methods And Compositions For Treatment Of Myelodysplastic Syndromes And/or Acute Myeloid Leukemias App 20210299102 - Starczynowski; Daniel ;   et al. | 2021-09-30 |
Compositions And Methods For Treating Cancer App 20200345712 - Nassar; Nicolas ;   et al. | 2020-11-05 |
Methods and Compositions for the Treatment of RAS Associated Disorders App 20130345268 - Ratner; Nancy ;   et al. | 2013-12-26 |
Methods and Compositions for the Treatment of RAS Associated Disorders App 20120302581 - Ratner; Nancy ;   et al. | 2012-11-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.